Compelo Medical Devices - Latest industry news and analysis is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More
Close
Dismiss

Alfa Wassermann unveils ACE Axcel Clinical Chemistry system

Alfa Wassermann Diagnostic Technologies has unveiled its ACE Axcel Clinical Chemistry system, designed for use in physician office labs to process up to 285 tests per hour with both photometric and potentiometric detection technologies.

The FDA-approved self-contained ACE Axcel system features an open reagent system that enables custom assays and a STAT interrupt that allows users to load and prioritize STAT samples during system operation to meet immediate diagnosis and treatment needs.

In addition, ACE Axcel system includes a touch screen functionality, an intuitive user interface and Internet connectivity to make in-office laboratory testing faster, more convenient and more cost-effective.

The company said ACE Axcel provides accurate results by using closed-tube sampling with the STEP module and on-board reagent refrigeration feature to maintain specimen integrity and decrease handling, according to the company.

Family Care Medical Practice spokesperson Dr. John Chafos said features such as the touch screen control panel, high degree of automation, and reduction of sample and reagent handling have the potential to increase the productivity of the practice lab operations.

"In addition, Internet connectivity will enable a higher level of technical support, a valuable benefit for our medical technologists," Chafos added.

Alfa Wassermann Diagnostic Technologies marketing and business development vice president Trip Trepagnier said, "ACE Axcel automates and simplifies the testing process, while our nationwide network of award-winning service and support personnel ensures that our customers can rapidly deliver high quality diagnostic test results with maximum productivity and minimum hassle."